Delivery Order SPE2DB22D1106-SPE2DB25FEZD2
Award Date 7/22/25
Potential Completion Date 7/23/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,427.90 to AmerisourceBergen Drug Corp for Doxorubicin 200 mg/100 mL vials on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single-line pharmaceutical procurement executed under the company's larger contract vehicle with DLA. The product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,126.05 to AmerisourceBergen Drug Corp for Doxorubicin Liposome 50mg/25ml on July 31, 2025, with completion scheduled for August 1, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a continuation of AmerisourceBergen's established relationship with the federal government as a critical pharmaceutical distributor. The order is being fulfilled from the vendor's location in...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Doxorubicin Liposome 50mg/25ml in 25ml units, with a ceiling value of $1,796.98. The contract is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded without set-aside designation. This delivery order is...
- This is a $1,500 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 30, 2024. The contract is for the delivery of 50mg/25ml doxorubicin liposome, a specialty medication, with a performance period ending January 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,400.00 fixed-price delivery order is for the supply of 4,564,081,943 units of Doxorubicin Liposome 20mg/10ml 10ml, a specialty pharmaceutical product, with a performance period through March 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,500.00. The contract is for the delivery of 4563492985 - Doxorubicin Liposome 50mg/25ml, a specialty pharmaceutical product, to support military healthcare programs. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 IDC...
- The Defense Logistics Agency awarded a $714 delivery order to Amerisourcebergen Drug Corporation for doxorubicin hydrochloride injection. The product will be delivered from the contractor's facility in Conshohocken, Pennsylvania to an unknown customer by July 14, 2023. The firm fixed price order was issued under an unspecified multiple award contract vehicle. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the United...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,004.85 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its broader contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,440.70 to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...